Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$508K Buy
8,726
+6,079
+230% +$712K 0.08% 126
2026
Q1
$318K Sell
2,647
-66
-2% -$7.62K 0.06% 172
2025
Q4
$286K Sell
2,713
-455
-14% -$42.7K 0.07% 167
2025
Q3
$266K Buy
3,168
+2,315
+271% +$191K 0.06% 176
2025
Q2
$69.5K Buy
853
+222
+35% +$17.6K 0.02% 305
2025
Q1
$55.2K Buy
631
+575
+1,027% +$53.7K 0.02% 339
2024
Q4
$5.57K Buy
56
+5
+10% +$515 ﹤0.01% 410
2024
Q3
$5.79K Buy
+51
New +$6.06K ﹤0.01% 393

Other funds holding MRK

ORG Wealth Partners's MRK Position: Q2 2026 in Review

ORG Wealth Partners increased its Merck (MRK) stake by 230% in Q2 2026, buying an estimated $712K and bringing the position to 8,726 shares worth $508K. The position accounts for 0.08% of the portfolio, ranked #126.

ORG Wealth Partners first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • ORG Wealth Partners held 8,726 shares of Merck worth $508K as of Q2 2026.
  • ORG Wealth Partners bought 6,079 Merck shares in Q2 2026, an estimated $712K.
  • Merck made up 0.08% of ORG Wealth Partners's portfolio in Q2 2026, its #126 holding.
  • ORG Wealth Partners first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.